The latest closing stock price for Larimar Therapeutics as of September 18, 2024 is 6.85.
An investor who bought $1,000 worth of Larimar Therapeutics stock at the IPO in 2014 would have $-971 today, roughly -1 times their original investment - a -29.84% compound annual growth rate over 10 years.
The all-time high Larimar Therapeutics stock closing price was 616.08 on March 19, 2015.
The Larimar Therapeutics 52-week high stock price is 13.68, which is 99.7% above the current share price.
The Larimar Therapeutics 52-week low stock price is 2.18, which is 68.2% below the current share price.
The average Larimar Therapeutics stock price for the last 52 weeks is 6.66.
An investor who bought $1,000 worth of Larimar Therapeutics stock at the IPO in 2014 would have $-971 today, roughly -1 times their original investment - a -29.84% compound annual growth rate over 10 years.
The all-time high Larimar Therapeutics stock closing price was 616.08 on March 19, 2015.
The Larimar Therapeutics 52-week high stock price is 13.68, which is 99.7% above the current share price.
The Larimar Therapeutics 52-week low stock price is 2.18, which is 68.2% below the current share price.
The average Larimar Therapeutics stock price for the last 52 weeks is 6.66.